11 June 1999
Urine Excretion of Transforming Growth Factor-beta I in Chronic Allograft Nephropathy
Maria BoratynskaAnn Transplant 1999; 4(2): 23-28 :: ID: 497449
Abstract
Transforming growth factor-beta 1(TGF-beta I)a multifunctional growth cytokine, has been implicated in the pathogenesis of chronic allograft nephropathy (chgn). The primary objective of the present study was to establish whether or not concentration ofTGFbeta 1in the sera and urine of transplant patients might be regarded as a chgn diagnostic factor and chgn activity indicator. Another objective was to investigate the response of this growth factor to arterial hypertension and metabolic disorder. Examined were 34 patients with chgn (Group I), 50 patients with a stable allograft function (Group II), and 25 healthy subjects (control). Follow-up since transplantation was 76:t34 months in patients of Group I and 59:t36 months in patients of Group II. Both groups of patients received maintenance triple immunosuppressive therapy. In all the subjects examined, determinations were carried out for serum and urine levels of TGF-beta 1 by the immunoenzymatic method. Hypertension was found in all patients of Group I and in 60% of patients of Group II; low levels of HDL cholesterol below ImM were observed in 52% of Group I patients and in 22% of Group II patients. Serum concentrations ofTGF-{:11were similar in all the subjects examined. Patients with chgn showed elevated urine excretion of TGF-{:1I,as compared to patients with no graft dysfunction or to the control. Urine excretion of TGF-beta 1 was noticeably higher in patients with developed interstitial tissue fibrosis (I-st degree of interstitial fibrosis 6.8:t4.9nglmg cr. vs. 13.3:t4.7ng1mg cr. in III-rd degree of fibrosis). Urinary TGF-beta 1 levels were correlated with arterial blood pressure, but they had a negative correlation with the HDL cholesterol level. Conclusions; I) In chronic renal graft rejection urine secretion ofTGF-beta 1 was increased; 2) Urine secretion ofTGF-beta was associated with arterial hypertension, degree of interstitial tissue fibrosis, and progression of graft insufficiency; 3) The negative correlation between HDL level and urine secretion of TGF-beta 1(both in patients with chronic rejection and in recipients with a stable graft function) suggests the influence of dyslipidemia on the secretion of this growth factor.
Keywords: Kidney Transplantation, TGF-beta I, chronic allograftnephropathy, Hypertension, HDL
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860